All Stories

  1. Psychiatric pharmacists improve patient access to quality healthcare

    Article • Psychiatric Services, March 2024, American Psychiatric Association

    Carla Cobb, Talia Puzantian, Michael Shuman

  2. Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states

    Article • Drug and Alcohol Dependence, August 2022, Elsevier

    Talia Puzantian

  3. Pharmacy students' perceptions of the effectiveness of a film-based mental health elective course

    Article • Currents in Pharmacy Teaching and Learning, January 2022, Elsevier

    Talia Puzantian

  4. Pharmacist furnishing of naloxone in California: A follow-up analysis

    Article • Journal of the American Pharmacists Association, September 2021, Elsevier

    Talia Puzantian

  5. Provision of Naloxone Without a Prescription by California Pharmacists 2 Years After Legislation Implementation

    Article • JAMA, November 2018, American Medical Association (AMA)

    Talia Puzantian

  6. Chapter 28: Psychiatric Patients

    Article • May 2018, American Society of Health System Pharmacists

    Talia Puzantian

  7. Book Review: Clinical handbook of psychotropic drugs, 19th revised edition

    Article • Mental Health Clinician, May 2012, College of Psychiatric and Neurologic Pharmacists (CPNP)

    Talia Puzantian

  8. Central Nervous System Adverse Effects with Efavirenz: Case Report and Review

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, July 2002, Wiley

    Talia Puzantian

  9. Liquid Risperidone in the Treatment of Psychotic Agitation

    Article • CNS Drugs, January 2002, Springer Science + Business Media

    Talia Puzantian

  10. Ecstasy: Dangers and Controversies

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, December 2001, Wiley

    Talia Puzantian

  11. Book Review: Comprehensive Care of Schizophrenia: A Textbook of Clinical Management

    Article • Annals of Pharmacotherapy, December 2001, SAGE Publications

    Talia Puzantian

  12. Comprehensive Care of Schizophrenia: A Textbook of Clinical Management

    Article • Annals of Pharmacotherapy, December 2001, SAGE Publications

    Talia Puzantian

  13. Psychiatric Pharmacists

    Article • American Journal of Psychiatry, December 2001, American Psychiatric Association

    Talia Puzantian

  14. Prediction of Valproate Serum Concentrations in Adult Psychiatric Patients Using Bayesian Model Estimations With NPEM2 Population Pharmacokinetic Parameters

    Article • Therapeutic Drug Monitoring, June 1999, Wolters Kluwer Health

    Talia Puzantian

  15. Does the Addition of Pindolol Accelerate or Enhance the Response to Selective Serotonin Reuptake Inhibitor Antidepressants?

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, February 1999, Wiley

    Talia Puzantian

  16. Mirtazapine, an antidepressant

    Article • American Journal of Health-System Pharmacy, January 1998, Oxford University Press (OUP)

    Talia Puzantian

  17. Drs. Puzantian and Shaw Reply

    Article • The Journal of Clinical Psychiatry, August 1997, Physicians Postgraduate Press, Inc

    Talia Puzantian

  18. Nefazodone and Neurotoxicity

    Article • The Journal of Clinical Psychiatry, August 1997, Physicians Postgraduate Press, Inc

    Talia Puzantian

  19. Nefazodone and Symptoms Suggesting Neurotoxicity

    Article • The Journal of Clinical Psychiatry, December 1996, Physicians Postgraduate Press, Inc

    Talia Puzantian

  20. Criteria for use of valproate in adult psychiatric inpatients and outpatients

    Article • American Journal of Health-System Pharmacy, May 1996, Oxford University Press (OUP)

    Talia Puzantian